Trial
NCT05306873
Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
—
Condition
Systemic Lupus Erythematosus
Intervention
Mycophenolate Mofetil
Why stopped
The study was closed due to slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-09